Medical Xpress news
Medical Xpress / Blocking a cellular inflammation process could result in effective therapy for pancreatic cancer
Scientists at The Wistar Institute and clinical researchers from ChristianaCare's Helen F. Graham Cancer Center & Research Institute have discovered a vulnerability in pancreatic cancer that could be targeted as a potential ...
Medical Xpress / Liquid biopsy predicts response to breast cancer immunotherapy
Immunotherapy has become a standard of care in treating high-risk, early-stage breast cancers, yet it has had limited success in shrinking tumors. New biomarkers that can improve outcomes for patients are urgently needed. ...
Medical Xpress / Blood vessels activate self-defense response that may slow atherosclerosis progression
A study by researchers at Baylor College of Medicine and collaborating institutions reveals a previously unrecognized way blood vessels can protect themselves from damage and slow the development of atherosclerosis. The findings, ...
Medical Xpress / Lithium not working? Large-scale study highlights favorable treatment strategies for bipolar disorder
Bipolar disorder is a mental health condition estimated to affect between 1% and 3% of people worldwide. Its main symptoms include extreme mood swings, ranging from periods of high activity and emotional high (i.e., mania) ...
Medical Xpress / A brownie, a drink, a drive: Hidden impairment standard sobriety tests completely miss
Johns Hopkins Medicine researchers have added to evidence that using cannabis edibles and alcohol together worsens driving impairment compared with consuming either substance alone. The study also found that cannabis (alone ...
Medical Xpress / Experimental KRAS G12D drug slows cancer growth, shrinks tumors in early test
A first-in-human clinical trial led by an international team of researchers and published in the New England Journal of Medicine found that setidegrasib, an investigational targeted therapy drug designed to eliminate a key ...
Medical Xpress / Physicians benefit from AI when making nuanced clinical decisions, study shows
Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For example, how long before ...
Medical Xpress / Cold skin, hot heart, one gene: Hidden temperature switch decides where disease appears
The saying "cold hands, warm heart" is usually meant metaphorically—but new research from UC Davis School of Medicine and collaborating institutions suggests it has a striking biological parallel.
Medical Xpress / Cell-by-cell analysis uncovers 345 risk genes across six neuropsychiatric disorders
The emergence of neuropsychiatric disorders, conditions that affect various brain functions and behaviors, is known to be driven by an intricate combination of factors. These can include both a genetic predisposition and ...
Medical Xpress / FDA approves once-daily Idvynso tablet for treating HIV
The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug single tablet for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen ...
Medical Xpress / Early brain regions play greater role in decision-making, challenging traditional neuroscience
New insight into decision-making pathways in the brain may impact the way engineers think about artificial intelligence, according to new research from The Grainger College of Engineering at the University of Illinois Urbana-Champaign. ...
Medical Xpress / Reverse engineering ketamine's effects may lead to new antidepressants
Weill Cornell Medicine investigators have "reverse engineered" ketamine's antidepressant effects to identify potential new strategies for treating depression. While there are many effective treatments available for depression, ...
